Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN12559751
ISRCTN12559751
Completed
Phase 4

An interventional, double-blind randomized parallel-group, phase IV study for the assessment of a tailored Opioid therapy and osteoarthritic chronic pain bioMarkers, to improve Arthoprosthesis patients rehabilitation (OpMarkArt)

ISAL Foundation0 sites60 target enrollmentMay 23, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
ISAL Foundation
Enrollment
60
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2017 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/29258584

Registry
who.int
Start Date
May 23, 2017
End Date
November 23, 2017
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ISAL Foundation

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients who started opioid analgesics category and will undergo total hip arthroplasty for osteoarthritis or aseptic necrosis of the femoral head
  • •2\. Patients who started NonSteroidal Anti\-Inflammatory Drugs (NSAIDs) and will undergo total hip arthroplasty (THA) for osteoarthritis or aseptic necrosis of the femoral head
  • •3\. Males and female adults (from 18 years old)

Exclusion Criteria

  • •1\. Unstable neurological pathologies
  • •2\. Uncompensated diabetes
  • •3\. Previous abdominal surgery with dynamic ileum risk
  • •4\. Viral infective pathologies
  • •5\. Patients unable to fill the informed consent form
  • •6\. Patients needing post\-surgery mechanical ventilation
  • •7\. Patients attending a secondary surgery
  • •8\. Retreated patients

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Rituximab versus cyclophosphamide in connective tissue disease-ILDInterstitial lung disease in people with severe connective tissue disease, including systemic sclerosis, idiopathic interstitial myopathy (including polymyositis/dermatomyositis) and mixed connective tissue diseaseRespiratory
ISRCTN16474148Royal Brompton & Harefield NHS trust104
Completed
Not Applicable
ow-dose intravenous immunoglobulin treatment for Complex Regional Pain Syndrome
ISRCTN42179756niversity of Liverpool (UK)108
Completed
Phase 2
Innovations in the management of musculoskeletal pain with alpha-lipoic acid
ISRCTN58259979Physicians Services Incorporated Foundation27
Completed
Not Applicable
Melatonin for nocturia in multiple sclerosis (MS)Topic: Renal and Urogenital, Nocturia in adults with multiple sclerosisUrological and Genital DiseasesNocturia
ISRCTN38687869orth Bristol NHS Trust (UK)50
Completed
Phase 3
Speed of Increasing milk Feeds Trial
ISRCTN76463425niversity of Oxford (UK)2,804